Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
seriously, do you realize how the folks in this department make up their calls and BS their way on everything? It's amazing how they continue to get away with this!
Why are infusion centers still complaining about losses related to infusion of Tysabri? Is'nt this something that we can control? Price increases, discounts to wholesalers, managed care etc all combine to determine available margin to the clinician. What's happening?
managed markets is the place to be folks. Make up account calls and blame sales for poor performance! Tier 3, so what, learn to sell against it! Shifting blame is the best thing these folks do! 5 office days a week!